Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Addex Pharma S.A.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with an established diagnosis of idiopathic benign essential blepharospasm
Must have had prior response to to botulinum toxin (BoNT) reported on last 2 consecutive injection cycles
Last injection of BoNT at least 8 weeks prior to Screening assessments
Patient is experiencing features of Blepharospasm (BSP) of moderate severity/frequency at study entry.
You may not be if
BSP that is known or suspected to be associated with a known cause such as neuroleptic exposure, brain injury or lesion, stroke, Parkinson's disease, or related Parkinsonisms
History of surgical intervention (e.g., deep brain stimulation) or orbital myectomy for dystonia
Disabling eyelid opening apraxia
Other neurological disease (including psychiatric disease and/or cognitive impairment) that, in the opinion of the investigator, would affect the patient's ability to complete study assessments.
Other significant medical condition that may affect the safety of the patient or preclude adequate participation in the study.
